vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and INSEEGO CORP. (INSG). Click either name above to swap in a different company.
Cytek Biosciences, Inc. is the larger business by last-quarter revenue ($62.1M vs $48.4M, roughly 1.3× INSEEGO CORP.). INSEEGO CORP. runs the higher net margin — 1.0% vs -70.9%, a 71.9% gap on every dollar of revenue. On growth, Cytek Biosciences, Inc. posted the faster year-over-year revenue change (8.1% vs 0.6%). INSEEGO CORP. produced more free cash flow last quarter ($11.6M vs $-1.8M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs 13.6%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
Inseego Corp designs, manufactures and delivers advanced 5G and IoT solutions including mobile hotspots, edge computing devices, and cloud-based device management platforms. It primarily serves telecom operators, enterprise clients, and public sector customers across global markets.
CTKB vs INSG — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $48.4M |
| Net Profit | $-44.1M | $469.0K |
| Gross Margin | 52.9% | 42.2% |
| Operating Margin | -9.0% | 2.7% |
| Net Margin | -70.9% | 1.0% |
| Revenue YoY | 8.1% | 0.6% |
| Net Profit YoY | -557.1% | 182.9% |
| EPS (diluted) | — | $-0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | $48.4M | ||
| Q3 25 | $52.3M | $45.9M | ||
| Q2 25 | $45.6M | $40.2M | ||
| Q1 25 | $41.5M | $31.7M | ||
| Q4 24 | $57.5M | $48.1M | ||
| Q3 24 | $51.5M | $54.0M | ||
| Q2 24 | $46.6M | $51.6M | ||
| Q1 24 | $44.9M | $37.5M |
| Q4 25 | $-44.1M | $469.0K | ||
| Q3 25 | $-5.5M | $1.4M | ||
| Q2 25 | $-5.6M | $507.0K | ||
| Q1 25 | $-11.4M | $-1.6M | ||
| Q4 24 | $9.6M | $-566.0K | ||
| Q3 24 | $941.0K | $9.0M | ||
| Q2 24 | $-10.4M | $624.0K | ||
| Q1 24 | $-6.2M | $-4.5M |
| Q4 25 | 52.9% | 42.2% | ||
| Q3 25 | 52.7% | 41.6% | ||
| Q2 25 | 52.3% | 41.1% | ||
| Q1 25 | 48.6% | 47.3% | ||
| Q4 24 | 58.5% | 37.3% | ||
| Q3 24 | 56.3% | 34.8% | ||
| Q2 24 | 54.6% | 36.4% | ||
| Q1 24 | 51.3% | 35.3% |
| Q4 25 | -9.0% | 2.7% | ||
| Q3 25 | -17.6% | 4.7% | ||
| Q2 25 | -23.3% | 3.2% | ||
| Q1 25 | -36.1% | -1.3% | ||
| Q4 24 | 5.2% | 3.7% | ||
| Q3 24 | -8.2% | 1.9% | ||
| Q2 24 | -18.3% | 3.6% | ||
| Q1 24 | -23.9% | -7.9% |
| Q4 25 | -70.9% | 1.0% | ||
| Q3 25 | -10.5% | 3.1% | ||
| Q2 25 | -12.2% | 1.3% | ||
| Q1 25 | -27.5% | -5.0% | ||
| Q4 24 | 16.8% | -1.2% | ||
| Q3 24 | 1.8% | 16.6% | ||
| Q2 24 | -22.4% | 1.2% | ||
| Q1 24 | -13.8% | -11.9% |
| Q4 25 | — | $-0.02 | ||
| Q3 25 | — | $0.03 | ||
| Q2 25 | — | $-0.03 | ||
| Q1 25 | — | $-0.16 | ||
| Q4 24 | — | $0.62 | ||
| Q3 24 | — | $-0.06 | ||
| Q2 24 | — | $-0.02 | ||
| Q1 24 | — | $-0.44 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | $24.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $341.7M | $-4.0M |
| Total Assets | $461.5M | $93.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | $24.9M | ||
| Q3 25 | $93.3M | $14.6M | ||
| Q2 25 | $75.5M | $13.2M | ||
| Q1 25 | $95.3M | $35.1M | ||
| Q4 24 | $98.7M | $39.6M | ||
| Q3 24 | $162.3M | $12.0M | ||
| Q2 24 | $177.9M | $49.0M | ||
| Q1 24 | $168.8M | $12.3M |
| Q4 25 | $341.7M | $-4.0M | ||
| Q3 25 | $378.6M | $-7.7M | ||
| Q2 25 | $377.6M | $-10.5M | ||
| Q1 25 | $379.6M | $-13.0M | ||
| Q4 24 | $395.7M | $-12.9M | ||
| Q3 24 | $385.5M | $-85.1M | ||
| Q2 24 | $389.1M | $-101.8M | ||
| Q1 24 | $392.6M | $-105.6M |
| Q4 25 | $461.5M | $93.8M | ||
| Q3 25 | $494.9M | $85.8M | ||
| Q2 25 | $493.3M | $83.1M | ||
| Q1 25 | $482.6M | $93.0M | ||
| Q4 24 | $499.5M | $100.0M | ||
| Q3 24 | $491.2M | $113.4M | ||
| Q2 24 | $483.7M | $149.6M | ||
| Q1 24 | $492.1M | $122.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $12.0M |
| Free Cash FlowOCF − Capex | $-1.8M | $11.6M |
| FCF MarginFCF / Revenue | -2.9% | 24.0% |
| Capex IntensityCapex / Revenue | 1.6% | 0.7% |
| Cash ConversionOCF / Net Profit | — | 25.50× |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | $6.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | $12.0M | ||
| Q3 25 | $-3.9M | $3.2M | ||
| Q2 25 | $108.0K | $-4.5M | ||
| Q1 25 | $-125.0K | $-3.5M | ||
| Q4 24 | $2.0M | $-14.2M | ||
| Q3 24 | $13.2M | $14.8M | ||
| Q2 24 | $6.2M | $27.6M | ||
| Q1 24 | $4.0M | $5.2M |
| Q4 25 | $-1.8M | $11.6M | ||
| Q3 25 | $-4.6M | $3.1M | ||
| Q2 25 | $-1.5M | $-4.7M | ||
| Q1 25 | $-974.0K | $-3.5M | ||
| Q4 24 | $1.1M | $-14.3M | ||
| Q3 24 | $12.2M | $14.8M | ||
| Q2 24 | $5.2M | $27.6M | ||
| Q1 24 | $3.4M | — |
| Q4 25 | -2.9% | 24.0% | ||
| Q3 25 | -8.7% | 6.7% | ||
| Q2 25 | -3.2% | -11.6% | ||
| Q1 25 | -2.3% | -11.0% | ||
| Q4 24 | 1.9% | -29.7% | ||
| Q3 24 | 23.7% | 27.4% | ||
| Q2 24 | 11.0% | 53.5% | ||
| Q1 24 | 7.6% | — |
| Q4 25 | 1.6% | 0.7% | ||
| Q3 25 | 1.3% | 0.2% | ||
| Q2 25 | 3.5% | 0.5% | ||
| Q1 25 | 2.0% | 0.1% | ||
| Q4 24 | 1.6% | 0.1% | ||
| Q3 24 | 2.0% | 0.0% | ||
| Q2 24 | 2.3% | 0.0% | ||
| Q1 24 | 1.3% | 0.0% |
| Q4 25 | — | 25.50× | ||
| Q3 25 | — | 2.22× | ||
| Q2 25 | — | -8.81× | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | 14.05× | 1.65× | ||
| Q2 24 | — | 44.31× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
INSG
Segment breakdown not available.
